Antiva Biosciences News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at Antiva Biosciences

• Kristine Ball, President and Chief Executive Officer
• Clifford Samuel, Director
• Elizabeth Stoner, Director

Popular executive movements at Antiva Biosciences

• Ann Warsi, Vice President and Head of Clinical Development, has left the company  (posted on July 1 2026).

Create your alert
to follow the executive moves at Antiva Biosciences.

Antiva Biosciences has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Antiva Biosciences

• Antiva Press Release
• Antiva Press Release
• Antiva Press Release
• Antiva Press Release
• Antiva Press Release

Social media about Antiva Biosciences

• Antiva Biosciences on Wikipedia, Google News & Yahoo Finance
• Antiva Biosciences on LinkedIn, X (Twitter) & YouTube